![Wen Luo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Wen Luo
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Denovo Biopharma Co., Ltd.
![]() Denovo Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Denovo Biopharma Co., Ltd. is a clinical-stage biopharmaceutical company based in Beijing, China. Denovo Biopharma uses novel biomarker approaches to execute efficient clinical trials in targeted patient populations to optimize the probability of successful trials. The Chinese company has eight late clinical stage drugs in its pipeline addressing major unmet medical needs in oncology and CNS diseases, most of which are first-in-class drugs with rights. Denovo Biopharma seeks to discover genomic biomarkers correlated with patients' responses to drug candidates retrospectively. The company designs and executes efficient clinical trials in targeted patient populations to optimize the probability of a successful trial. Denovo Biopharma is enrolling patients in a phase 3 clinical trial for its lead asset db102 (enzastaurin) in diffuse large B-cell lymphoma (DLBCL) and will start a phase 2b study in glioblastoma (GBM). The company has four additional late-stage programs targeting major unmet needs\: db103 for schizophrenia, db104 for depression, db105 for Alzheimer's disease, and db106 for acute myeloid leukemia (AML). Denovo Biopharma is a next-generation biomarker partner to personalize your drug. The company was founded in 2012 by Wen Luo.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Wen Luo tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Denovo Biopharma LLC
![]() Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
SINOCARE INC. | Medical Specialties | Director/Board Member | |
National Chengchi University | College/University | Undergraduate Degree | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Cina | 2 |
Taiwan | 2 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni
Chief Operating Officer | 2 |
Director/Board Member | 2 |
Founder | 1 |
Director of Finance/CFO | 1 |
Corporate Secretary | 1 |
Contatti più connessi
Insiders | |
---|---|
Ji Zheng Chen | 4 |
Xiangming Fang | 2 |
- Borsa valori
- Insiders
- Wen Luo
- Connessioni Società